Nonavalent HPV vaccine
Sponsors
London School of Hygiene and Tropical Medicine, Xiamen University, University of British Columbia
Conditions
Cervical CancerCervical Intraepithelial NeoplasiaCondylomata AcuminataHPVHuman Immunodeficiency VirusHuman Papilloma Virus
Phase 3
A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
Active, not recruitingNCT02834637
Start: 2017-02-23End: 2027-03-01Updated: 2026-09-08
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Active, not recruitingNCT04537156
Start: 2020-09-05End: 2027-12-31Updated: 2025-11-21